Investigational New Drugs

Published by: Springer  

People

  1. Lis
    Lis
  2. Pfister
    Pfister
  3. Schwartz
    Schwartz
  4. Shaha
    Shaha
  5. Shah
    Shah
  6. Singh
    Singh
  7. Wolden
    Wolden

Groups

  1. Radiology, Department of (2)
  2. Body Imaging Service (1)
  3. Center for Hematologic Malignancies (1)
  4. Department of Medicine (1)
  5. Head and Neck Service (1)
  6. Interventional Radiology Service (1)
  7. Pediatric Leukemia (1)
  8. Radiation Oncology, Department of (1)
  9. Solid Tumor Oncology Division (1)
  10. Surgery (1)
Search Within
  1. "2002"
Formats
  1. Journal Article (2)
Groups
  1. Radiology, Department of (2)
  2. Body Imaging Service (1)
  3. Center for Hematologic Malignancies (1)
  4. Department of Medicine (1)
  5. Head and Neck Service (1)
  6. Interventional Radiology Service (1)

More Groups

People
  1. Andrew Huvos (1)
  2. Andrew Zahalsky (1)
  3. Ashok Shaha (1)
  4. Bhuvanesh Singh (1)
  5. David Pfister (1)
  6. Dennis Kraus (1)

More People

Years
  1. 2002 (2)
Publishers
  1. Springer (2)

Results (2)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of arsenic trioxide in patients with metastatic renal cell carcinoma
    Journal Article

    Vuky, J.; Yu, R.; Schwartz, L.; Motzer, R. J.
    Investigational New Drugs (2002)

    Fulltext@MSK | Save
  • A phase II trial of bryostatin-1 in patients with metastatic or recurrent squamous cell carcinoma of the head and neck
    Journal Article

    Pfister, D. G.; McCaffrey, J.; Zahalsky, A. J.; Schwartz, G. K.; Lis, E.; Gerald, W.; Huvos, A.; Shah, J.; Kraus, D.; Shaha, A.; more...
    Investigational New Drugs (2002)

    Fulltext@MSK | Save

    • Investigational New Drugs – authorized name for:

    Name ISSN / ISBN Publisher
    Investigational New Drugs 01676997 Springer Science + Business Media, LLC
    Investigational New Drugs 0167-6997 Unknown
    Investigational New Drugs 01676997 2023, The Author(s), Under Exclusive Licence To Springer Science+business Media, Llc, Part of Springer Nature
    Investigational New Drugs 01676997 Kluwer Academic Publishers
    Investigational New Drugs 0167-6997 Springer
    Investigational New Drugs 0167-6997 Springer
    Investigational New Drugs 01676997 Springer
    Investigational New Drugs 0167-6997 Kluwer Academic Publishers
    Investigational New Drugs 01676997 Springer Science + Business Media, LLC
    Investigational New Drugs 0167-6997 Martinus Nijhoff Publishers
    Investigational New Drugs 01676997 2020, The Author(s)
    Investigational New Drugs 0167-6997 Springer
    Investigational New Drugs 0167-6997 Springer
    Investigational New Drugs 15730646 Springer Science + Business Media, LLC
    Investigational New Drugs 0167-6997 Springer
    Investigational New Drugs 0167-6997 Springer
    Investigational New Drugs 15730646 Unknown
    Investigational New Drugs 0167-6997 Springer
    Investigational New Drugs 0167-6997 Springer
    Investigational New Drugs 15730646 Springer Science + Business Media, LLC
    Investigational New Drugs 01676997 2019, Springer Science+business Media, Llc, Part of Springer Nature
    Investigational New Drugs 01676997 2019, The Author(s)
    Investigational New Drugs 01676997 Springer Science + Business Media, LLC
    Investigational New Drugs 01676997 Springer Science + Business Media, LLC
    Investigational New Drugs 0167-6997 Springer
    Investigational New Drugs 0167-6997 Springer
    Investigational New Drugs 01676997 Unknown
    Investigational New Drugs 0167-6997 Springer
    Investigational New Drugs 01676997 Springer Science + Business Media, LLC
    Investigational New Drugs 0167-6997 Springer
    Investigational New Drugs 01676997 2017, Springer Science+business Media New York
    Investigational New Drugs 01676997 Springer Science + Business Media, LLC
    Investigational New Drugs 0167-6997 Springer Nature
    Investigational New Drugs 01676997 Springer Science+Business Media New York
    Investigational New Drugs 01676997 The Author(s)
    Investigational New Drugs 01676997 Springer
    Investigational New Drugs 01676997 2018, The Author(s)
    Investigational New Drugs 0167-6997 Springer
    Investigational New Drugs 0167-6997 Kluwer Academic Publishers
    Investigational New Drugs: An Interdisciplinary Journal for Clinicians and Scientists 01676997 Unknown